Evidence map›Paper›PMID 42199451›Full record

ArticleCancer management and research2026

The Luo-Dingyuan Thyroid Vascular-Lymphatic Segmentation Classification: A Functional Anatomy-Based Framework to Facilitate Precision Management and Thyroid Function Preservation.

Dingyuan Luo

Abstract read
In one paragraph

Article in Cancer management and research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Dingyuan LuoDepartment of Thyroid Surgery, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, People's Republic of China.ORCID 0000-0002-3009-2589

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Hypothyroidism remains a common and clinically significant consequence of thyroid surgery, frequently necessitating long-term or lifelong thyroid hormone replacement therapy, which may be associated with adverse effects on cardiovascular health and bone metabolism. In the era of treatment de-escalation, active surveillance and local ablation have emerged as important management. However, both require precise anatomical localization and rational definition of treatment boundaries. Therefore, a precise anatomical framework that enables function-preserving management without compromising oncologic safety is urgently needed. The study proposes and comprehensively describes a novel, anatomy-based segmental classification of thyroid, the Luo-Dingyuan Segmental Classification (Luo Segmental Classification), to explore its potential clinical applications. Methods: The Luo Segmental Classification was developed through an integrated analysis of classical thyroid anatomy, vascular territories, and lymphatic drainage patterns. Each thyroid lobe is divided longitudinally into upper, middle, and lower thirds and further subdivided into anterior and posterior segments according to depth and vascular-lymphatic orientation, resulting in six reproducible segments per lobe. The isthmus and pyramidal lobe are defined as an independent anatomical unit. Potential clinical applications were evaluated conceptually in imaging, surgery, active surveillance, and ablation. Results: The thyroid can be consistently divided into anatomically and functionally meaningful segments corresponding to distinct vascular and lymphatic territories. Based on this principle, the classification enabled standardized anatomical localization of thyroid nodules across ultrasonography (US), computed tomography (CT), and magnetic resonance imaging (MRI). Segment-based localization allowed precise description of tumor position, facilitated individualized treatment planning, and provided a unified anatomical language bridging radiology, surgery, pathology, and interventional therapy. Overall, this framework supported standardized reporting, individualized management, and potential reduction of unnecessary thyroid tissue loss and permanent hypothyroidism. Conclusion: The Luo Segmental Classification provides an anatomy-based framework to promote precise and individualized management of thyroid cancer, support function-preserving strategies, and address unmet clinical needs.

Indexed as

function-preserving surgeryhypothyroidismLuo segmental classificationthyroid cancervascular-lymphatic anatomy

Identifiers

PMID42199451
PMCPMC13199731

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.